Immunomodulatory Effects of Neuroleptics to the Cytokine System and the Cellular Immune System in Schizophrenia

  • N. Müller
  • M. Riedel
  • M. Schwarz
  • R. Gruber
  • M. Ackenheil
Part of the Key Topics in Brain Research book series (KEYTOPICS)


The influence of an immune process on the pathogenesis of psychoses has been under discussion since the 1920s, when immune disturbances in schizophrenia, especially in catatonia, were reported by different authors (Bruce and Peebles, 1903; Dameshek, 1930; Lehmann-Facius, 1939).


Schizophrenic Patient Visceral Leishmaniasis Neuroleptic Treatment Peripheral Immune System BioI Psychiatry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baker GA, Syntalo R, Blumenstein J (1977) Effects of psychotropic agents upon the blastogenic response on human T-lymphocytes. Biol Psychiatry 12:159–169PubMedGoogle Scholar
  2. Banks WA, Kastin AJ (1992) The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier. Int J Immunopharmacol 14: 629 – 636PubMedCrossRefGoogle Scholar
  3. Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson WD jr (1991) Soluble IL-2 receptors as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147: 281 – 284PubMedGoogle Scholar
  4. Berman JS, Mahoney K, Saukkonen JJ, Masuyama J (1995) Migration of distinct sub sets of CD8+ blood cells through endothelial cell monolayers in vitro. J Leukoc Biol 58: 317 – 324PubMedGoogle Scholar
  5. Bertini S, Bianchi M, Mengozzi M, Ghezzi P (1989) Protective effect of chlorpromazine against the lethality of interleukin 1 in adrenalectomized or actinomycin D-sensitized mice. Biochem Biophys Res Commun 165: 942 – 947PubMedCrossRefGoogle Scholar
  6. Bertini S, Garattini R, Delgado P, Ghezzi P (1993) Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology 79: 217 – 219PubMedGoogle Scholar
  7. Brivio S, Lissoni P, Mancini D, Tisi E, Tancini G, Barni S, Nociti V (1991) Effect of antitumor surgery on soluble interleukin-2 receptor serum levels. Am J Surg 161: 466 – 469PubMedCrossRefGoogle Scholar
  8. Bruce LC, Peebles AMS (1903) Clinical and experimental observations on catatonia. J Ment Sci 49: 614 – 628Google Scholar
  9. Burkly LC, Jakubowski A, Newman BM, Rosa MD, Chi-Rosso G, Lobb RR (1991) Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation. Eur J Immunol 21: 2871 – 2875PubMedCrossRefGoogle Scholar
  10. Dameshek W (1930) White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatry 24: 855Google Scholar
  11. Denicoff KD, Rubinoff DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107: 293 – 300PubMedGoogle Scholar
  12. Del Val M, Münch K, Reddehase MJ, Koszinowski UH (1991) Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 58: 305 – 315CrossRefGoogle Scholar
  13. De Vries HE, Moor ACE, Blom-Roosemalen MCM, de Broer AG, Breimer DD, van Berkel TJC, Kuiper J (1994) Lymphocyte adhesion to brain capillary endothelial cells in vitro. J Neuroimmunol 52: 1 – 8PubMedCrossRefGoogle Scholar
  14. Fabry Z, Raine CS, Hart MN (1994) Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 15: 218 – 224PubMedCrossRefGoogle Scholar
  15. Gallien M, Schnetzler JP, Morin J (1977) Antinuclear antibodies and lupus cells in 600 hospitalized phenothiazine treated patients. Ann Med Psychol Med 1: 237 – 248Google Scholar
  16. Ganguli R, Rabin BS (1989) Increased serum interleukin 2 receptor levels in schizophrenic and brain damaged subjects. Arch Gen Psychiatry 46: 292PubMedGoogle Scholar
  17. Ganguli R, Rabin BS, Kelly RH, Lyte M, Ragu U (1987) Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann NY Acad Sci 496: 676 – 685PubMedCrossRefGoogle Scholar
  18. Ganguli R, Yang Z, Shurin G, Chengappa R, Brar JS, Gubbi AV, Rabin BS (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51: 1 – 10PubMedCrossRefGoogle Scholar
  19. Ganguli R, Brar JS, Chengappa KR, DeLeo M, Yang ZW, Shurin G, Rabin B (1995a) Mitogen-stimulated interleukin 2 production in never-medicated, first episode schizophrenics - the influence of age of onset and negative symptoms. Arch Gen Psychiatry 52: 878Google Scholar
  20. Ganguli R, Brar JS, Rabin BS (1995b) Reply on: Pollmacher T etal.: Clozapine-in- duced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry 52: 668 – 672Google Scholar
  21. Gruber R, Hadjamu M, Riedel M, Schwarz M, Primbs J, Ackenheil M, Müller NGoogle Scholar
  22. (1997c) CD8+ memory T-lymphocytes (CD45RO+) are elevated in unmedicated schizophrenic patients while CD4+CD45RO+ and CD4+HLADR+ T-cells increase during treatment with neuroleptics. Am J Psychiatry (submitted)Google Scholar
  23. Guidotti LC, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 91: 3764 – 3768PubMedCrossRefGoogle Scholar
  24. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from post-natal, two-week-old rats in cultures. Neurosci 40: 445 – 452CrossRefGoogle Scholar
  25. Hampel H, Schwarz M, Kotter HU, Schneider C, Muller N (1996) Cell adhesion molecules in the central nervous system. Drug News & Perspect 9: 69 – 81Google Scholar
  26. Héry C, Sébire G, Peudenier S, Tardieu M (1995) Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulating by cytokines. J Neuroimmunol 57: 101 – 109PubMedCrossRefGoogle Scholar
  27. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H (1995) Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res 15: 237 – 242PubMedCrossRefGoogle Scholar
  28. Hornung N, Raskova J, Raska K, Degiannis D (1992) 11–2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants. Int J Immunopharmacol 14:753–760Google Scholar
  29. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated levels of interleukin-2 in neuroleptic-free schizophrenics. Am J Psychiatry 150: 1408 – 1410PubMedGoogle Scholar
  30. Lehmann-Facius H (1939) Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg Z Psychiatrie 110: 232 – 243Google Scholar
  31. Mackiewicz A, Schooltink H, Heinrich PC, Rose-John S (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 49: 2021 – 2027Google Scholar
  32. Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89: 346 – 351PubMedCrossRefGoogle Scholar
  33. Maes M, Bosmans E, Ranjan R, Vandoolaeghe B, Meltzer HY, De Ley M, Berghmans R, Stans G, Desnyder R (1996) Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr Res 21: 39 – 50PubMedCrossRefGoogle Scholar
  34. McAllister CG, Rapaport MH, Pickar D, Paul SM (1989) Effect of short term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients. Arch Gen Psychiatry 46: 956 – 957PubMedGoogle Scholar
  35. McAllister CG, van Kammen DP, Rehn TJ, Miller AN, Gurklis J, Kelley ME, Yao J, Peters JL (1995) Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrance of psychosis and medication status. Am J Psychiatry 152: 1291 – 1297PubMedGoogle Scholar
  36. Müller N, Ackenheil M (1995a) The immune system and schizophrenia. In: Leonard BE, Miller K (eds) Stress, the immune system and psychiatry. Wiley and Sons, Chichester, pp 137 – 164Google Scholar
  37. Müller N, Ackenheil M (1995b) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: the relationship to negative symptomatology. Schizophr Res 14: 223 – 228CrossRefGoogle Scholar
  38. Müller N, Ackenheil M (1995b) Immunoglobulin and albumin contents of cerebrospinal fluid in schizophrenic patients: the relationship to negative symptomatology. Schizophr Res 14: 223 – 228CrossRefGoogle Scholar
  39. Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R (1991) Cellular immunity in schizophrenic patients before and during neuroleptic therapy. Psychiatry Res 37: 147 – 160PubMedCrossRefGoogle Scholar
  40. Müller N, Dobmeier P, Empl M, Riedel M, Schwarz M, Ackenheil M (1997) Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients. Eur Psychiatry 12: 294 – 299PubMedCrossRefGoogle Scholar
  41. Müller N, Dobmeier P, Empl M, Riedel M, Schwarz M, Ackenheil M (1997) Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients. Eur Psychiatry 12: 294 – 299PubMedCrossRefGoogle Scholar
  42. Müller N, Hadjamu M, Riedel M, Primbs J, Ackenheil M, Gruber R (1997c) Adhesion- molecule receptor expression on T-cells and the role of the blood-brain barrier in schizophrenia. Am J Psychiatry (submitted )Google Scholar
  43. Niewiesk S, Brinckmann U, Bankamp B, Sirak S, Liebert UG, ter Meulen V (1993) Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T-lymphocytes. J Virol 67: 75 – 81PubMedGoogle Scholar
  44. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE (1991) Differential utilisation of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T-lymphocytes. J Immunol 147: 2913 – 2921PubMedGoogle Scholar
  45. Plata-Salaman CR, Ffrench-Mullen JM (1993) Interleukin-2 modulates calcium cur-rents in dissociated hippocampal CA1 neurons. Neuroreport 4: 579 – 581PubMedCrossRefGoogle Scholar
  46. Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F (1995) Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry 52: 877 – 878PubMedGoogle Scholar
  47. Raine CS, Canella B, Duijvestijn AM, Cross AH (1990) Homing to central nervous vasculature by antigen-specific lymphocytes. II Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest 63: 476 – 479PubMedGoogle Scholar
  48. Ransohoff RM, Benveniste EN (1996) Cytokines and the CNS. CNC Press NY, London Rapaport MH, McAllister CG, Pickar D, Nelson DM, Paul SM (1989) Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry 46: 292Google Scholar
  49. Rapaport MH, McAllister CG, Kirch DG, Pickar D (1990) The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol Psychiatry 29: 715 – 717CrossRefGoogle Scholar
  50. Rapaport MH, Torrey EF, McAllister CG, Nelson DM, Pickar D, Paul SM (1993) Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci 243:7-10 Rapaport MH, McAllister CG, Kim YS, Han JH, Pickar D, Nelson DM, Kirch DG, Paul SM (1994) Increased soluble interleukin-2 receptors in caucasian and korean schizophrenic patients. Biol Psychiatry 35: 767 – 771Google Scholar
  51. Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem Acta 163: 319 – 328CrossRefGoogle Scholar
  52. Russo R, Ciminale M, Ditommaso S, Siliquini R, Zotti C, Ruggenini AM (1994) Hepatitis B vaccination in psychiatric patients. Lancet 343: 394CrossRefGoogle Scholar
  53. Saunders JC, Muchmore E (1964) Phenothiazine effect on human antibody synthesis. Br J Psychiatry 110: 84 – 89PubMedCrossRefGoogle Scholar
  54. Sawada M, Suzumura A, Marunouchi T (1992) TNF-alpha induces IL-6 production by astrocytes, but not by microglia. Brain Res 583: 296 – 299PubMedCrossRefGoogle Scholar
  55. Schleuning MJ, Duggan A, Reem GH (1989) Inhibition by chlorpromazine of lym-phokine-specific m-RNA expression in human thymocytes. Eur J Immunol 19: 1491 – 1496PubMedCrossRefGoogle Scholar
  56. Schleuning M, Brumme V, Wilmanns W (1994) Inhibition of cyclosporin A/FK 506 resistant, lymphokine-induced T-cell activation by phenothiazine derivates. Naunyn Schmiedebergs Arch Pharmacol 350: 100 – 103PubMedCrossRefGoogle Scholar
  57. Schöbitz B, Pezeshki G, Pohl T, Hermann U, Heinrich PC, Holsboer F, Reul JM (1995) Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J 9: 659 – 664PubMedGoogle Scholar
  58. Smith RS (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 39: 248 – 257PubMedCrossRefGoogle Scholar
  59. Townsend A, Bastin J, Gold K, Brownlee G, Andrew B, Coupar B, Boyle D, Chan S, Smith G (1988) Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168: 1211 – 1224PubMedCrossRefGoogle Scholar
  60. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Genestet D, Loo H, Zarifarain E, Bach JF (1989) Aberrant T-cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 146: 609 – 616PubMedGoogle Scholar
  61. Waguespack PJ, Banks WA, Kastin AJ (1994) Interleukin-2 does not cross the blood-brain-barrier by a saturable transport system. Brain Res Bull 34: 103 – 109PubMedCrossRefGoogle Scholar
  62. Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 246: 279 – 284PubMedCrossRefGoogle Scholar
  63. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643:40–49PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • N. Müller
    • 1
  • M. Riedel
    • 1
  • M. Schwarz
    • 1
  • R. Gruber
    • 2
  • M. Ackenheil
    • 1
  1. 1.Psychiatric HospitalLudwig-Maximilian UniversityMunichFederal Republic of Germany
  2. 2.Institute of ImmunologyLudwig-Maximilian UniversityMunichFederal Republic of Germany

Personalised recommendations